Stopping Aminosalicylate Therapy in Inactive Crohn's Disease
If you have Crohn's disease and your symptoms are currently settled (in remission), you might be taking a medication called 5-ASA. This study wants to find out if it's safe and effective for people with Crohn's to stop taking 5-ASA, rather than continuing with it. While 5-ASA is very helpful for a similar condition called ulcerative colitis, its benefits for Crohn's disease are less clear, especially when symptoms are already under control. Participants will either keep taking their 5-ASA or stop it entirely. The researchers will then carefully watch for two years to see if those who stop the medication stay well, compared to those who continue taking it. The aim is to see if stopping 5-ASA is not much worse than continuing it for keeping Crohn's in remission.
Auf einen Blick
Worum geht es in dieser Studie?
This research study is about a medication commonly used for Crohn's disease called 5-ASA. If you have Crohn's, you might be taking 5-ASA, especially if your symptoms are currently settled and you're feeling well (this is called being in remission). While 5-ASA is known to be very effective for a similar condition called ulcerative colitis, doctors are not entirely sure how much it helps people with Crohn's disease when their symptoms are already under control. This study hopes to answer that question.
The main aim is to see if people with Crohn's disease who are in remission can safely stop taking their 5-ASA medication without their symptoms returning. In this study, some people will continue taking 5-ASA as usual, while others will stop. The researchers will then compare these two groups over a period of two years to see if there's a big difference in how well they stay. This is important because it could help doctors understand the best way to manage Crohn's disease in the long term, potentially reducing the number of medications some people need to take.
By comparing these two approaches, the study will help doctors and patients make more informed decisions about 5-ASA treatment for Crohn's disease. The ultimate goal is to improve care and quality of life for people living with this condition.
Wichtige Erkenntnisse
- This study evaluates stopping 5-ASA medication for Crohn's disease in remission.
- It aims to see if stopping 5-ASA is as effective as continuing it over two years.
- Participants will be randomly assigned to either stop or continue their medication.
- The study helps understand the best long-term treatment for Crohn's disease.
- You'll receive close monitoring and care during the two-year study period.
Wer könnte berechtigt sein?
To join this study, you need to be an adult (18 years or older) with a confirmed diagnosis of Crohn's disease for at least three months. You must currently be taking an oral 5-ASA medication for at least six months and be regularly taking it (at least 75% of your prescribed doses). Importantly, your Crohn's disease symptoms must be settled and under control (in remission) when you join the study. You also need to be able to fully take part in all study activities and give your written permission to join.
There are some reasons why you wouldn't be able to join. For example, if you have other bowel conditions like ulcerative colitis or diverticular disease, or if you have serious active problems with Crohn's like fistulas or active infections around your bottom. If you've had a recent flare-up of your Crohn's that needed new or increased medication, or if you've recently taken strong steroid medicines for your Crohn's, you wouldn't be eligible. Also, if you've had major bowel surgery for Crohn's in the last six months, or if you're unwilling to stop taking 5-ASA for the study, you wouldn't be able to take part. The study also cannot include you if you have other serious health problems or are currently in another research study that might get in the way.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- Sind Sie 18 Jahre oder älter?
- Do you have a diagnosis of Crohn's disease, confirmed at least 3 months ago?
- Have you been taking oral 5-ASA medication for at least 6 months, and take it regularly?
- Are your Crohn's disease symptoms currently settled and in remission?
- Have you avoided major bowel surgery for Crohn's in the last 6 months?
- Are you able to agree to either continue or stop your 5-ASA medicine as part of the study?
Was beinhaltet die Teilnahme?
If you decide to take part in this study, you'll first be assessed to make sure you meet all the requirements. Once you're in, you'll be randomly assigned to one of two groups: either you'll continue taking your current 5-ASA medication, or you'll stop taking it. This decision is made by chance, like flipping a coin. You won't know which group you're in until after this assignment.
You will need to attend regular check-ups and assessments over a period of two years (24 months). These visits will involve discussions about your health, any symptoms you might be experiencing, and possibly some tests to monitor your Crohn's disease. The researchers will be closely watching to see how your Crohn's disease behaves, whether you continue or stop your 5-ASA. The total commitment for this study will last for two years.
Potenzielle Risiken und Vorteile
Locations (46)
- University of CalgaryVerifizierte PostleitzahlCalgary, Kanada
- University of AlbertaVerifizierte PostleitzahlEdmonton, Kanada
- Dr. Jesse Siffledeen Professional Medical CorporationVerifizierte PostleitzahlEdmonton, Kanada
- (G.I.R.I.) GI Research InstituteVerifizierte PostleitzahlVancouver, Kanada
- Discovery Clinical Services Ltd.Verifizierte PostleitzahlVictoria, Canada
- University of Manitoba - Health Sciences CentreVerifizierte PostleitzahlWinnipeg, Kanada
- London Health Sciences Centre - University HospitalVerifizierte PostleitzahlLondon, Kanada
- Scott Shulman Medical Professional CorporationVerifizierte PostleitzahlNorth Bay, Canada
- Taunton Surgical CenterVerifizierte PostleitzahlOshawa, Canada
- Mount Sinai HospitalVerifizierte PostleitzahlToronto, Kanada
- Dr. O. Tarabain Medicine Professional CorporationVerifizierte PostleitzahlWindsor, Canada
- McGill University HealthcareVerifizierte PostleitzahlMontreal, Kanada
Häufige Fragen
What is 5-ASA?
5-ASA is a type of medicine often used to manage inflammatory bowel conditions like Crohn's disease and ulcerative colitis.
What does 'remission' mean for Crohn's disease?
Remission means that your Crohn's disease symptoms are currently settled, and you're feeling well, without active inflammation.
Will I get to choose whether I stop or continue my medicine?
No, in this study, you will be randomly assigned to either stop or continue your 5-ASA, like how a flip of a coin works.
Wie lange wird die Studie dauern?
The study will involve regular check-ups and monitoring for a period of two years (24 months).
What if my Crohn's symptoms get worse during the study?
Your health will be closely monitored, and if your symptoms worsen, the study doctors will provide appropriate care and you can withdraw from the study.
Wie Sie mehr erfahren können
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.